Transcript Highlights:

• Chairman, the 340B drug program is a federal program for pharmaceutical companies that choose to participate
• The legal ambiguity of the bill is compounded by the practical risk it poses to user safety, specifically

Summary: Senate State Affairs began by taking up HCR 31, a resolution honoring former Representative Lyndon Bateman. Senator Anthon, Tess Molitor, and former Lieutenant Governor David Leroy spoke in tribute, describing Bateman’s long legislative service, his work on Idaho Day, his advocacy for cursive and Idaho history, and his humor and letter-writing. The committee moved HCR 31 to the Senate floor with a due pass recommendation, and the motion carried. The committee then heard gubernatorial appointments to the State Building Authority from Nicholas Gouho and Todd Christensen, both of whom outlined extensive backgrounds in construction, development, finance, and public service. The committee also considered and approved confirmations for Robert Donaldson and Irving Littman to the Idaho Endowment Fund Investment Board, sending both to the floor with recommendations for confirmation. Several RS requests were introduced and sent to print, including measures on liability protections for polling places, a legislative salary reduction resolution, revisions to 340B drug reporting, surveyor access, and cremation identification requirements. The committee also advanced HB 637 on gold and silver legal tender, HB 573 expanding who may teach enhanced concealed carry courses, and HB 561 on government flag displays. HB 542, the social media bill aimed at limiting addictive features and requiring age estimation and parental controls for minors, drew extensive testimony both for and against; after debate over the effective date and private cause of action, the committee sent it to the 14th order for possible amendments rather than directly to the floor.

Transcript Highlights:

• Phil Chris Finnelli with the Pharmaceutical Care Management Association.
• They negotiate discounts with large pharmaceutical manufacturers.
• They negotiate discounts with large pharmaceutical manufacturers.
• It will result in higher drug prices, it will result in more pharmaceutical manufacturer profits, and
• Ultimately, drug prices are set by the pharmaceutical manufacturer.

Summary: The House Insurance Committee met on April 1 with a quorum present and first took up House Bill 938 by Rep. Turner, which would overhaul pharmacy benefit manager (PBM) regulation by setting a flat administration fee, requiring dispensing fees and NADAC-based reimbursement, mandating rebate pass-through, giving the Department of Insurance access to PBM data, and creating a reverse-auction process for PBM procurement. Turner said the bill is intended to level the playing field for independent pharmacies, improve transparency, and reduce hidden PBM practices. The committee adopted amendment set 1444 without objection, and Turner said additional conceptual amendments were still being worked on. Supporters included independent pharmacies and the PBM Accountability Project; opponents included union plan representatives, benefits consultants, and PBM/insurance industry witnesses who warned of higher costs, ERISA preemption problems, and likely litigation. After extended questioning on cost, preemption, and vertical integration, the committee reported HB 938 with amendments. The committee then considered House Bill 870, also by Rep. Turner, dealing with formulary placement and cost-sharing for generic drugs and biosimilars and limiting certain utilization management practices. Amendment set 1540 was adopted, revising and tightening technical definitions. Turner and a representative of the Association for Accessible Medicines argued the bill would help lower-cost generics and biosimilars gain market share and reduce patient costs, citing examples such as insulin and Humira biosimilars. Opponents from Louisiana Blue said the bill would force coverage based on wholesale acquisition cost rather than net cost, would raise premiums for fully insured members, and would mandate coverage of drugs that are not always the lowest net-cost option. Rep. Jordan again raised ERISA and preemption concerns, and committee members discussed whether the bill would interfere with tiering and plan design. After closing comments and a motion by Rep. Glorioso, HB 870 was reported with amendments, and the committee adjourned.

Transcript Highlights:

• Um, the impact of the pharmaceutical restrictions is not hypothetical.
• > impact of the pharmaceutical impact of the pharmaceutical restrictions<00:25:35.919><c> is</c><00:25
• </c><00:29:24.720><c> companies</c> made by the pharmaceutical companies made by the pharmaceutical companies
• Goo or I don't pharmaceutical guys, Mr.
• </c> concerns that the pharmaceutical concerns that the pharmaceutical companies<00:30:59.360><c> have

Keywords: 912, senate, all

Summary: The committee heard testimony on HB 302, which would expand access to medical cannabis by removing the in-person provider-patient relationship requirement and related restrictions. The Department of Health supported the bill, and multiple advocates and organizations testified in support, including the ACLU of Hawaii, Hawaii Alliance for Cannabis Reform, Marijuana Policy Project, and others. Supporters said the measure would improve access for patients, especially on outer islands, and some urged broader amendments allowing providers to certify cannabis for any medical condition and to speed registration and treat in-state and out-of-state patients equally. No opposition was heard, and the bill was left with no questions after testimony. The committee also heard HB 1052 HD1, which clarifies that the Public Utilities Commission may use universal service fund monies to provide free telecommunications access for individuals with print disabilities. Testimony was uniformly supportive from the DCCA Division of Consumer Advocacy, the State Council on Developmental Disabilities, the Department of Human Services, the Public Utilities Commission, and the National Federation of the Blind of Hawaii. Witnesses described the program as an important accessibility service that has been operating under prior appropriations and should continue under the universal service program. HB 1482, relating to controlled substances and hemp/synthetic cannabinoids, drew support from the Department of Law Enforcement, Department of Health, Honolulu Police Department, and others, with some comments from the Attorney General’s office. Supporters said the bill would clarify that delta-8 THC is a controlled substance and help enforcement against illegal hemp products and synthetic cannabinoids. Testimony and questioning focused on the need for better lab testing capacity, retail registry and age-gating, seizure authority, nuisance abatement, and possible use of special funds or appropriations to support enforcement. Members also discussed enforcement of illegal hemp businesses and whether additional funding or statutory changes would be needed. Finally, the committee took up HB 712, a 340B drug-discount measure affecting safety-net providers and contract pharmacies. Hospitals, health centers, and provider groups testified in support, saying the bill would protect access to discounted drugs and preserve funding for services such as chronic disease management, transportation, and specialty care. Pharmaceutical-industry representatives opposed the bill or sought amendments, arguing the 340B program has expanded beyond its original intent and lacks transparency, and they requested reporting or audit-like provisions to verify claims and revenues. Members questioned both sides about alleged abuse, the growth of contract pharmacies, and whether the bill should include transparency requirements before moving forward.

Transcript Highlights:

• Looking forward, there's been incredible technology and changes in pharmaceuticals.
• We know that the pharmaceutical companies that produce OxyContin provided false information that was
• and Analysis, which was established as part of that pharmaceutical law.
• pharmaceutical access. ...looking at the intersection of pharmaceutical policy and pharmaceutical access
• I'm not sure for the Office of Pharmaceutical Policy and Analysis, OPPA—really important work.

Summary: The hearing was a Joint Committee on Ways and Means budget session on health and human services, held in Clinton and opened with remarks from the House and Senate co-chairs, local officials, and committee members. The chairs emphasized the importance of hearing directly from agencies about the Commonwealth’s health care and human services budget needs, thanked Clinton for hosting, and introduced the day’s panels, beginning with the Executive Office of Health and Human Services (EOHHS) and then MassHealth. Secretary Kiame Mahania presented Governor Healey’s FY27 EOHHS budget, describing a $33.7 billion request driven largely by non-discretionary cost growth, caseload increases, and federal uncertainty. He highlighted targeted investments in foster parent reimbursement, family resource centers, maternal health, food assistance, immigrant legal services, and workforce rates, while warning that federal cuts and the Trump administration’s One Big Beautiful Bill Act could strip billions from state health funding. Members questioned him about primary care shortages, federal program integrity audits, ConnectorCare, regional health disparities, and the proposed cap on adult dental coverage; he defended the cap as a difficult but necessary cost-control measure and said the administration would continue cooperating with federal partners. Undersecretary Michael Levine then testified for MassHealth, saying the agency faces two major challenges: rapid cost growth and looming federal changes. He outlined a $22.7 billion gross MassHealth budget and proposed actions including a moratorium on new expansions, capping adult dental benefits at $1,000, ending GLP-1 coverage for weight loss only, reducing care management spending to peer-state levels, and convening work groups to slow growth in personal care attendant, adult foster care, and adult day health programs. He also warned that federal policy changes could cause about 300,000 residents to lose coverage by 2030 and reduce federal revenue by about $3.5 billion, and said MassHealth would use outreach and systems changes to help eligible members stay covered. Members raised concerns about the impact of these cuts on homeless care, preventive services, dental access, GLP-1s, and regional hospital and specialist shortages, while Levine argued the proposals were aimed at preserving core coverage and sustainability.

Transcript Highlights:

• The 340B program allows us to have discounted pharmaceuticals that are our folks would not be able to
• My name is Kyle, and I am the Director of State Policy for Pharmaceutical Research and Manufacturers
• Various different pharmaceutical companies that either limit the number of contract pharmacies.
• They're going to say, we're going to give you your pharmaceuticals.
• Our clinics absolutely cannot front enough money to cover pharmaceuticals on a refund program.

Transcript Highlights:

• major 21st century manufacturing zones that we have had located for automotive industry-related, pharmaceuticals
• related,</c> located for automotive industry related, located for automotive industry related, pharmaceuticals
• , pharmaceuticals, pharmaceuticals, uh uh uh semiconductor,<00:06:46.760><c> etc.

Bills: SB325, SB370

Keywords: AIDT, Alabama Industrial Development Training Institute, Department of Commerce, procurement, competitive bidding, contract review, legislative oversight, economic development, workforce development, Strategic Workforce Plan, state purchasing, state contracts, public procurement, exemption, higher education, universities, community colleges, public hospitals, health care procurement, transportation procurement

Transcript Highlights:

• Um very briefly our pharmaceutical work.
• </c> that prohibits pharmaceutical that prohibits pharmaceutical manufacturers<01:03:36.000><c> from<
• </c> the last two years with pharmaceutical the last two years with pharmaceutical manager<01:03:54.079
• It's more like pharmaceutical companies.
• > give</c><01:42:20.800><c> us</c><01:42:20.960><c> a</c> pharmaceutical company to give us a pharmaceutical

Keywords: 919, house, all

Summary: The committee first approved the March 11, 2026 minutes, then heard House File 4048, which would exempt chiropractors from Minnesota’s provider tax if they are no longer eligible to provide chiropractic benefits under Medicaid/MinnesotaCare. Representative Robbins said the bill corrects an unfair situation because chiropractors still pay the tax even though the benefit was eliminated. Testifiers from the Minnesota Chiropractic Association and a longtime chiropractor supported the bill, arguing that most chiropractors are small-business owners and should not pay a tax for services they can no longer provide. Several members said they supported restoring chiropractic coverage instead of changing the tax, and there was discussion about whether the tax applies to all providers and whether it is effectively passed on to patients. The committee adopted a motion to recommend HF 4048 to the Committee on Taxes. The committee then took up House File 3893, as amended, a bill to restrict artificial intelligence from engaging in psychotherapy or counseling with humans. The author and supporters said the bill is intended to prevent AI chatbots from posing as therapists or counseling vulnerable people, citing reports of suicides and other harms linked to chatbot interactions. The A2 amendment was adopted; the author said it reflected stakeholder concerns and added informed-consent language. Testifiers in support, including a psychologist and a suicide-prevention nonprofit leader, urged strong safeguards and said AI should not replace licensed professionals in crisis settings. Other testimony raised concerns about overbreadth and unintended effects. TechNet and a rural mental health provider said the bill should be narrowed so it applies to clinical therapy rather than wellness or educational tools, and should allow supervised AI uses such as transcription and administrative support. Members discussed rural access, existing licensing-board authority, privacy laws, and whether the bill should target AI companies directly rather than licensed clinicians. The transcript ends during continued discussion of HF 3893, with no final committee action shown in the excerpt.

Transcript Highlights:

• Pharmaceutical companies should just simply lower their prices.
• rebates pharmaceutical companies should just<00:36:25.960><c> simply</c><00:36:26.240><c> lower</c><
• So what's happening today is that the pharmaceutical chain has become a rather perverted, convoluted
• with the pharmaceutical Care Management Association<00:54:14.319><c> otherwise</c><00:54:14.680><c>
• </c> things are done at a pharmaceutic things are done at a pharmaceutic pharmacy<01:05:22.880><c> level

Keywords: 1187, senate, all

Transcript Highlights:

• The 4% increase the provider tax on pharmaceutical distributors.
• bands, you get into those old age bands and they're consuming a lot of those pharmaceuticals.
• bands, you get into those old age bands and they're consuming a lot of those pharmaceuticals.
• </c><01:15:15.120><c> companies</c> wholesale pharmaceutical companies wholesale pharmaceutical companies
• so what we're really Pharmaceuticals so what we're really doing<01:16:36.120><c> is</c><01:16:36.280

Keywords: 1187, senate, all

Transcript Highlights:

• With me today is Anneliese Steeber, who manages our pharmaceutical analysis and research work.
• SNAP cuts compound these challenges for retailers and will accelerate store closures in both urban and
• SNAP<01:16:19.000><c> cuts</c><01:16:19.280><c> compound</c><01:16:19.760><c> these</c><01:16:19.960>
• <c> challenges</c><01:16:20.480><c> for</c> SNAP cuts compound these challenges for SNAP cuts compound

Keywords: 1187, senate, all

Transcript Highlights:

• In the health care space, we're trying to hold pharmaceutical companies accountable and reduce the cost
• ><c> to</c><00:02:13.080><c> hold</c> space, we're trying to hold space, we're trying to hold pharmaceutical
• <00:02:13.920><c> companies</c><00:02:14.520><c> accountable</c><00:02:15.280><c> and</c> pharmaceutical
• companies accountable and pharmaceutical companies accountable and reduce<00:02:16.360><c> the</c><00

Keywords: 1183, house

Transcript Highlights:

• I think the pharmaceuticals... ...is the ones responsible for that bleeding.
• I think the pharmaceutical companies are rightly concerned that, you know, they participate in this program
• When it started in the 1990s, it was at the impetus of the pharmaceutical companies themselves.
• But pharmaceutical companies point to another set of court cases that show no, states really can't regulate
• And we also want to make sure that we're not punishing pharmaceutical companies and making it difficult

Summary: Republican legislative leaders used the availability to focus on affordability, budget pressures, and opposition to several Democratic tax proposals. They criticized a circulating draft income tax proposal as a de facto small-business tax, arguing it would hurt LLCs, S corporations, housing investment, and the broader economy. They also attacked a proposed tire fee, a possible cigarette tax increase, and other tax ideas as regressive or hidden from consumers, while saying Republicans would not support any tax increases and urging budget cuts and spending restraint instead. The leaders said they planned to raise these concerns in an upcoming meeting with Governor Ferguson, along with questions about his budget and how he reconciles prior opposition to a wealth tax with support for an income tax. They also discussed a bill to make it harder to qualify initiatives for the legislature, calling it anti-democratic, and said the majority was ignoring or undermining voter-driven policy efforts. On child welfare, they criticized DCYF oversight and supported stronger accountability, including a bill to fix the state’s “imminent harm” standard and another proposal to stop the state from collecting certain federal disability and survivor benefits from foster youth. Other topics included tort liability reform, where Republicans said the state’s repeated failures in child welfare and juvenile rehabilitation are the underlying problem, not just the cost of claims, though they were open to limited reforms such as disclosure of litigation financing. They also discussed the 340B drug pricing program, saying it is complicated and could affect hospitals, FQHCs, patients, and pharmaceutical innovation. On public safety and technology, they expressed cautious support for bills regulating kids’ social media and AI use, but stressed First Amendment concerns and the need to avoid private rights of action; they were more skeptical of a bill limiting police retention of automatic license plate reader data, saying law enforcement needs effective tools to solve crimes. No votes were taken, and the event ended with Republicans reiterating that affordability was their top priority.

Transcript Highlights:

• But unfortunately, in the last couple of years, there have been practices by some pharmaceutical companies
• actions, and following the lead of 21 states or 20-some-odd states, this bill would prohibit... ...pharmaceutical
• believe that this is something that we need to put in place because of the practices of certain pharmaceutical
• I believe that creating these limitations to what pharmaceutical companies, et cetera, can do would actually
• concerned, the reason why I believe this is necessary is precisely because the actions of some pharmaceutical

Keywords: 993, senate, all

Summary: The Health Committee met to consider a series of bills, many of them repeat proposals from prior sessions. Early measures included S.11 on disclosure for non-invasive prenatal screening, S.92 allowing redaction of certain physician names from birth certificates, S.135 creating practical support grants for abortion care, S.428A requiring chain restaurants to label high-sodium menu items, S.555 prohibiting visual images of people undergoing medical treatment without consent, and S.1614A establishing presumptive Medicaid eligibility for people leaving incarceration. The committee also advanced S.1438A to create an abortion clinical training program, S.1468 on access to medical records and limiting copy charges to actual cost, S.1619 expanding pharmacists’ authority to order and administer certain tests, and S.1714 banning the use of “excited delirium” as a diagnosis or cause of death. A substantial portion of the meeting focused on S.1633A, which would add protections for sensitive health information and allow patients to restrict disclosure of specified categories of data. One senator argued the bill could hinder care by limiting access to complete records, especially in emergencies, while supporters said the measure was needed to protect patients and providers from legal action by other states or the federal government, particularly in reproductive health cases. Staff clarified that the bill would allow segregation of specific sensitive data rather than locking an entire record. The committee also discussed S.1913, a 340B prescription drug anti-discrimination bill; supporters said it would protect safety-net providers and federally qualified health centers from pharmaceutical company practices, while one senator raised concerns about broad state intervention in a federal program. Additional bills advanced included S.5981 establishing a comprehensive sexual and reproductive health program, S.6178 directing a sickle cell disparity study, S.7457 permitting cremation or natural organic reduction for certain unclaimed decedents, S.7541 moving up reporting timelines for licensed home care services agencies, and S.8257A directing an alternative payment methodology for federally qualified health centers to support fertility care. Most bills were moved by committee vote, generally with some opposition or without recommendation, and were referred to first reading, rules, or finance as appropriate.

Transcript Highlights:

• So, to be clear, we're going to be appropriating funds to partner with the private pharmaceutical company
• Because my reading of it looks like it is using appropriated funds to give to a pharmaceutical company
• intent for this to be a temporary intervention or a permanent component of the state's approach to pharmaceutical
• Again, this is not about pharmaceutical access; this is about one drug that over 800,000 Oklahomans need
• I think insulin is a pharmaceutical, and we're talking about pharmaceutical access.

Bills: SJR47, SB1491, SB1579, SB1806, SB1552, SB483, SB63, SB137, SB346, SB514, SB1344, SB1360, SB1380, SB1437, SB1189, SB1217, SB1221, SB1262, SB1272, SB1325, SB1339, SB201

Keywords: voter ID, elections, constitutional amendment, Oklahoma, proof of identity, presidential electors, vacancies, oath of office, political party, property tax, valuation increase, taxpayer rights, homestead, protest process, foster care, adoption assistance, transitioning youth, Department of Human Services, voluntary services, county home rule charter

Bills: SJR47, SB1491, SB1579, SB1806, SB1552, SB483, SB63, SB137, SB346, SB514, SB1344, SB1360, SB1380, SB1437, SB1189, SB1217, SB1221, SB1262, SB1272, SB1325, SB1339, SB201

Keywords: voter ID, elections, constitutional amendment, Oklahoma, proof of identity, presidential electors, vacancies, oath of office, political party, property tax, valuation increase, taxpayer rights, homestead, protest process, foster care, adoption assistance, transitioning youth, Department of Human Services, voluntary services, county home rule charter

Transcript Highlights:

• We are going to be appropriating funds to partner with a private pharmaceutical company to produce insulin
• Because my reading of it looks like it is using appropriated funds to give to a pharmaceutical company
• Again, this is not to pharmaceutical access.
• I think insulin is a pharmaceutical, and we're talking about pharmaceutical access.
• I think insulin is a pharmaceutical, and we're talking about pharmaceutical access.

Bills: SJR47, SB1491, SB1579, SB1806, SB1552, SB483, SB63, SB137, SB346, SB514, SB1344, SB1360, SB1380, SB1437, SB1189, SB1217, SB1221, SB1262, SB1272, SB1325, SB1339, SB201

Keywords: voter ID, elections, constitutional amendment, Oklahoma, proof of identity, presidential electors, vacancies, oath of office, political party, property tax, valuation increase, taxpayer rights, homestead, protest process, foster care, adoption assistance, transitioning youth, Department of Human Services, voluntary services, county home rule charter

Summary: The Senate began with a quorum call, a ceremonial recognition of two Elgin High School students, Clayton Raoul and Leon Anderson, and bus driver Kevin McDonald for their heroic actions during a March 2 bus crash. A citation was read honoring their selfless efforts to evacuate injured students and assist first responders. The chamber also introduced several student pages and recognized visiting groups in the gallery, including Impact Oklahoma and the Ardmore Leadership Group. The Senate then considered several bills. Senate Bill 1491, requiring appointed presidential electors to take the same oath as other electors, advanced and passed. Senate Bill 1579, which requires assessors to mail taxpayers a statement of rights when property valuations increase, also advanced and passed unanimously. Senate Bill 1806, extending foster care eligibility to age 21 for those who opt in and meet program requirements, drew supportive debate about helping youth transition to adulthood; it advanced and passed as an emergency measure. A lengthy debate followed on Senate Bill 1552, which would allow certain large counties to pursue home rule charters through a voter-approved process. Supporters argued it would give populous counties more flexibility and local control, while opponents raised concerns about unequal treatment, population-based governance, rural representation, and possible constitutional issues. The bill advanced and then passed 26-18. Senate Bill 483, authorizing county-run relocation assistance programs funded by private donations for voluntarily relocating individuals, especially homeless persons, also prompted extensive questions about liability, trafficking concerns, accountability, and whether it could shift people between jurisdictions; it advanced and passed 39-6. Finally, Senate Bill 63, raising school board member stipends from $25 to $190 per meeting under permissive language, advanced over concerns about cost and then moved to final passage, with debate beginning at the end of the transcript.

Bills: HB117, HB17, HB22, HB153, HB140, HB117, HB17, HB22, HB153, HB140, SB12, SB42, SB93, SB28, SB35, SB134, SB12, SB42, SB93, SB28, SB35, SB134

Keywords: procurement, county commission, administrative savings, public services, government efficiency, HB17, municipal audits, municipal audit clarification act, municipal finance, local government, city council, mayor, city manager, Department of Examiners of Public Accounts, independent public accountant, annual audit, biennial audit, annual report, financial accountability, public records

Bills: HB25, HB108, HB109, HB111, HB112, HB113, HB117, HB118, HB119, HB120, HB121, HB122, HB124, HB126, HB127, HB128, HB129, HB130, HB131, HB25

Keywords: emergency services, 911, local districts, joint operations, contracting, HB108, Alabama Sunset Law, sunset reauthorization, board continuation, speech-language pathology, audiology, licensing board, professional regulation, healthcare regulation, occupational licensing, speech therapist, speech pathologist, audiologist, Sunset Committee, Code of Alabama 1975

Transcript Highlights:

• Are these for existing pharmaceutical companies? Are these generic drugs?”
• pharmaceutical...
• The Advanced Pharmaceutical Industry Innovation Center?” “Who is the company?
• The Advanced Pharmaceutical Industry Innovation Center.” “Okay, and so are the...
• “That pharmaceutical space.

Keywords: 959, house, all

Transcript Highlights:

• And that is a that is a list of of of pharmaceuticals that pharmaceuticals that pharmaceuticals that
• . retail pharmaceuticals. retail pharmaceuticals.
• industry formulary, the pharmaceutical industry formulary, the pharmaceutical industry either has to
• That's the way it used to be before the pharmaceutical used to be before the pharmaceutical used to be
• before the pharmaceutical benefit managers came into benefit managers came into benefit managers came

Bills: SCR 13, SCR 24, SB 1, SB 12, SB 15, SB 17, SB 24, SB 57, SB 65, SB 213, SB 371, SB 372, SB 378, SB 379, SB 388, SB 400, SB 402, SB 427, SB 495, SB 499, SB 502, SB 509, SB 535, SB 583, SB 610, SB 621, SB 650, SB 706, SB 740, SB 840, SB 854, SB 856, SB 875, SB 893, SB 918, SB 925, SB 974, SB 995, SB 1006, SB 1018, SB 1025, SB 1061, SB 1073, SB 1106, SB 1121, SB 1194, SB 1252, SB 1253, SB 1268, SB 1300, SB 1343, SB 1362, SB 1447, SJR 36, SJR 12, SJR 57, SCR 25, SCR 22, SCR 12, SCR 24, SCR 8, SB 565, SB 372, SB 765, SB 62, SB 666, SB 707, SB 888, SB 687, SB 847, SB 1248, SB 740, SB 14, SB 1006, SB 504, SB 925, SB 1121, SB 995, SB 857, SB 305, SB 296, SB 284, SB 815, SB 1379, SB 1300, SB 1497, SB 1499, SB 1498, SB 1061, SB 65, SB 241, SB 304, SB 402, SB 499, SB 621, SB 974, SB 1023, SB 1024, SB 1025, SB 1106, SB 686, SB 112, SB 371, SB 204, SB 400, SB 609, SB 1447, SB 670, SB 502, SB 427, SB 850, SB 854, SB 413, SB 1555, SB 1362, SB 1346, SB 1033, SB 1220, SB 1073, SB 810, SB 987, SB 1539, SB 893, SB 447, SB 875, SB 406, SB 509, SB 985, SB 965, SB 1119, SB 1505, SB 24, SB 57, SB 1194, SB 1253, SB 1215, SB 1532, SB 1268, SB 1302, SB 856, SB 650, SB 583, SB 673, SB 840, SB 213, SB 681, SB 1172, SB 1252, SB 378, SB 610, SB 918, SB 1343, SB 608, SB 487, SB 955, SB 957, SB 988, SB 990, SB 1019, SB 1021, SB 1120, SB 251, SB 958, SB 535, SB 761, SB 1, SB 541, SB 315, SB 379, SB 1018, SB 1737, SB 266, SB 1415, SB 57, SB 499, SB 974, SB 1025, SB 1061, SB 1268, SR 302, SR 303, SR 304, SR 305, SB 30, SB 1333, SB 1666, SB 30, SB 1333, SB 1666

Keywords: water rights, treaty compliance, Rio Grande, agriculture, drought, international water, Texas water supply, Texas, Israel, trade, investment, partnership, economic ties, technological innovation, bilateral relations, appropriations, budget, state funding, education, healthcare